The BRDC Story
The Beginning
Until recently, American corporations
and consumers did not greatly benefit from the $23 billion spent annually
on federal research. Why? Because new federally-funded technologydeveloped
in federal and academic labswas automatically deemed public property.
This arrangement had been
largely discouraging to corporate investment and development. After all,
why would corporations invest valuable research and development dollars
when the results will never be their own exclusive property?
An Alternative
In Peoria, Illinois, a group
of business leaders developed a bold alternative. Located near the USDA's
Northern Regional Research Lab, these leaders knew of the valuable research
conducted at the lab. And that a considerable amount of that research
never reached the actual marketplace.
So they began working on a
unique biotechnology consortium to bring federal, state, and private sectors
together in a close working relationship.
With ties to the USDAand
a focus on the agricultural applications of biotechnologytheir concept
generated immediate interest from several private research-oriented companies.
Licensing Issues
To overcome the hurdles of
public domain, the group worked with then U.S. House Minority Leader Robert
H. Michel (Peoria), Congressman Richard J. Durbin and U.S. Senator Robert
Dole (Kansas)then the Majority Leaderto introduce landmark
legislation allowing private companies to enter into research and development
agreements with federal labs. These agreements would also allow companies
to gain exclusive licensing rights to the resulting technologies.
With Michel leading the initiative,
the resulting Technology Transfer Act was signed into law by President
Reagan in 1986. With the private companies pledging specific dollars for
financial research support to the project, Congress appropriated research
funds for the new consortiumas did The State of Illinois.
The stage was set. The new
Biotechnology Research and Development Corporation (BRDC), a for-profit
corporation, was organized in 1988, and almost immediately began selecting
and funding research projects.
|